PATENT CLAIM ANALYSIS

Application Number: 16071938
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "221100"]

Abstract:
The present invention provides a live, attenuated coronavirus comprising a mutation in non-structural protein nsp-3 and/or deletion of accessory proteins 3a and 3b. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Claim (Index 24):
The method according to  claim 21  wherein the disease is infectious bronchitis (IB).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 95.0
- Lexical Diversity: 1.32432
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15328179', '13382119', '14888388', '10547219', '14887965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589886927662977
- 35 USC 102 Novelty (BERT): 0.6108341928072085
- Combined Prediction Score: 0.7441732427703888
- Mean Citation Score: 366.959088
- Max Citation Score: 551.06506
- Similarity Product: 499.13481834600935

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test